Calithera biosciences, inc. (CALA)
Income statement / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12
Revenue:
Total revenue

-

22,254

25,955

-

-

-

-

-

Operating expenses:
Research and development

76,290

66,195

43,111

27,748

23,748

16,367

9,900

6,558

General and administrative

16,605

13,340

12,530

10,586

9,071

5,354

2,478

1,417

Total operating expenses

92,895

79,535

55,641

38,334

32,819

21,721

12,378

7,975

Loss from operations

-92,895

-57,281

-29,686

-38,334

-32,819

-21,721

-12,378

-7,975

Interest and other income, net

3,035

2,652

1,860

-

-

-

-

-

Interest income, net

-

-

-

330

175

9

1

-

Net loss

-89,860

-54,629

-27,826

-38,004

-32,644

-21,712

-12,377

-7,975

Gain on extinguishment of convertible preferred stock

-

-

-

-

-

-

-

2,889

Net loss attributable to common stockholders

-

-

-

-

-

-

-

-5,086

Net loss per share, basic and diluted

-1.90

-1.49

-0.84

-1.95

-1.81

-4.67

-131.53

-366.13

Weighted average common shares used to compute net loss per share, basic and diluted

47,312

36,604

32,951

19,486

18,045

4,652

94

14